{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T21:37:25Z","timestamp":1770327445159,"version":"3.49.0"},"reference-count":24,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To investigate whether nebulised hypertonic saline (HS) treatment would decrease length of hospital stay (LOS) among infants with moderate-to severe-bronchiolitis compared with standard supportive care (SC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted an open, multicentre, randomised clinical trial from 1 April 2013 to 31 March 2016, in Swiss children\u2019s hospitals. Patients aged 6 weeks to 24 months with a primary diagnosis of moderate or severe bronchiolitis were included. Children with previous episodes of wheezing, cardiac disease, chronic respiratory disease, immunodeficiency, prematurity (gestational age &lt;34 weeks), corticotherapy in the preceding 2 weeks or inhaled bronchodilators within 24\u2009hours before presentation were excluded. Patients were randomised to receive standard SC with nebulisation of 4\u2009mL of 3% sodium chloride every 6\u2009hours versus SSC. Main outcomes and measures were LOS duration of oxygen therapy, transfer to intensive care unit (ICU), readmission within 7 days following discharge and adverse events.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>121 children were randomised. No statistically significant differences were found between treatment groups at baseline (age, Wang Score, atopic history, smoking exposure). Children in the HS group had a non-significant difference in length of stay \u22122.8\u2009hours (\u221210; 16) compared with the SC group. There were no differences in oxygen therapy duration, transfer to ICU, readmission rate or adverse events. The intervention was discontinued at the parents\u2019 request in 16% of the cases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study does not support the use of HS nebulisation in children with moderate to severe bronchiolitis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT01812525\">NCT01812525<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1136\/archdischild-2019-317160","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T21:15:15Z","timestamp":1567718115000},"page":"236-240","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Nebulised hypertonic saline in moderate-to-severe bronchiolitis: a randomised clinical trial"],"prefix":"10.1136","volume":"105","clinical-trial-number":[{"clinical-trial-number":"nct01812525","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Raphaelle","family":"Jaquet-Pilloud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Elise","family":"Verga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Gehri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9075-556X","authenticated-orcid":false,"given":"Jean-Yves","family":"Pauchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,9,5]]},"reference":[{"key":"2021052401051246000_105.3.236.1","unstructured":"Pfuntner A , Wier LM , Stocks C . Most frequent conditions in U.S. Hospitals, 2010: statistical brief #148. in: healthcare cost and utilization project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US), 2006. Available: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK127490\/"},{"key":"2021052401051246000_105.3.236.2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-2742"},{"key":"2021052401051246000_105.3.236.3","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMoa0804877","article-title":"The burden of respiratory syncytial virus infection in young children","volume":"360","author":"Hall","year":"2009","journal-title":"N Engl J Med Overseas Ed"},{"key":"2021052401051246000_105.3.236.4","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-0303"},{"key":"2021052401051246000_105.3.236.5","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31822e68e6"},{"key":"2021052401051246000_105.3.236.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2008.00245.x"},{"key":"2021052401051246000_105.3.236.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.acap.2014.06.008"},{"key":"2021052401051246000_105.3.236.8","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-1914"},{"key":"2021052401051246000_105.3.236.9","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21185"},{"key":"2021052401051246000_105.3.236.10","unstructured":"Nebulized hypertonic saline solution for acute bronchiolitis in infants - Zhang - 2008 -The Cochrane Library - Wiley Online Library. [cited 2016 Nov 16]. Available: http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/14651858.CD006458.pub2\/abstract;jsessionid=F4E6549FCAD199B67D21E1D7F7BE9D3A.f01t02"},{"key":"2021052401051246000_105.3.236.11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/jamapediatrics.2016.0079","article-title":"Association between hypertonic saline and hospital length of stay in acute viral bronchiolitis","volume":"170","author":"Brooks","year":"2016","journal-title":"JAMA Pediatr"},{"key":"2021052401051246000_105.3.236.12","doi-asserted-by":"crossref","unstructured":"Maguire C , Cantrill H , Hind D , et al . Hypertonic saline (HS) for acute bronchiolitis: systematic review and meta-analysis. BMC Pulm Med 2015;15:148.doi:10.1186\/s12890-015-0140-x","DOI":"10.1186\/s12890-015-0140-x"},{"key":"2021052401051246000_105.3.236.13","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/apa.13448","article-title":"Nebulised hypertonic saline inhalations do not shorten hospital stays in infants with bronchiolitis","volume":"105","author":"Heikkil\u00e4","year":"2016","journal-title":"Acta Paediatr"},{"key":"2021052401051246000_105.3.236.14","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.annemergmed.2016.07.001","article-title":"Is nebulized hypertonic saline solution effective for acute bronchiolitis?","volume":"69","author":"Chao","year":"2017","journal-title":"Ann Emerg Med"},{"key":"2021052401051246000_105.3.236.15","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-205953"},{"key":"2021052401051246000_105.3.236.16","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21108"},{"key":"2021052401051246000_105.3.236.17","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200204-293OC"},{"key":"2021052401051246000_105.3.236.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpem.2009.03.006"},{"key":"2021052401051246000_105.3.236.19","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/145.1.106"},{"key":"2021052401051246000_105.3.236.20","doi-asserted-by":"crossref","unstructured":"Zhang L , Mendoza-Sassi RA , Wainwright C . Nebulised hypertonic salinesolution for acute bronchiolitis in infants. In: Cochrane Database of Systematic Reviews [Internet]. John Wiley & Sons, Ltd, 2013. http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/14651858.CD006458.pub3\/abstract","DOI":"10.1002\/14651858.CD006458.pub3"},{"key":"2021052401051246000_105.3.236.21","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-1914"},{"key":"2021052401051246000_105.3.236.22","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ppul.23306","article-title":"A randomized trial of nebulized 3% hypertonic saline with salbutamol in the treatment of acute bronchiolitis in hospitalized infants","volume":"51","author":"Flores","year":"2016","journal-title":"Pediatr Pulmonol"},{"key":"2021052401051246000_105.3.236.23","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-1037"},{"key":"2021052401051246000_105.3.236.24","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jamapediatrics.2015.0681","article-title":"A living systematic review of nebulized hypertonic saline for acute bronchiolitis in infants","volume":"169","author":"Badgett","year":"2015","journal-title":"JAMA Pediatr"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2019-317160","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T08:09:42Z","timestamp":1621843782000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2019-317160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,5]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,2,20]]},"published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10.1136\/archdischild-2019-317160"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2019-317160","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,5]]}}}